Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction.
Sakhuja S, Bittner VA, Brown TM, Farkouh ME, Levitan EB, Safford MM, Woodward M, Chen L, Sun R, Dhalwani N, Jones J, Kalich B, Exter J, Muntner P, Rosenson RS, Colantonio LD.
Sakhuja S, et al. Among authors: levitan eb.
Cardiovasc Drugs Ther. 2023 Apr 13. doi: 10.1007/s10557-023-07452-1. Online ahead of print.
Cardiovasc Drugs Ther. 2023.
PMID: 37052867